After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
CBSE Result 2022: How was the CBSE 10th-12th result compared to the previous years, see here
CBSE Result 2022: The Central Board of Secondary Education/CBSE declared the results of both clas
Covid-19: Vaccination of adolescents of 15 to 18 years started - know the whole process
After several months of discussion, finally, from January 3, 2022, in India, adolescents in the a
Team India won the first T20 match against West Indies by 68 runs. Chasing the target of 191 runs
COVID-19: The number of new infected and active cases decreased sharply, 'bye-bye ba.5'
New cases of corona in the country are constantly fluctuating. In the last 24 hours, 9,531 new in
India is preparing to buy Predator drones from America. On Saturday, Navy Chief Admiral R Hari Ku
The date of the oath-taking ceremony of Telugu Desam Party chief Chandrababu Naidu as the Chief M
After the Indo-Pak ceasefire, External Affairs Minister S Jaishankar held talks with Afghanistan'
Prime Minister Narendra Modi will take out a road show on the streets of Kashi today amid the sou
The ongoing ODI series between Pakistan and Sri Lanka has been rescheduled following a suicide at
A shooting occurred just a short distance from the residence of President Donald Trump, the world
